Total assets expanded to $3.7B with debt-to-equity improving to 0.48, yet retained earnings fell from $402.2M to $206.2M over the past year, and cash dropped from $1.2B to $429.1M, signaling that equity growth is funded by external capital rather than internal profitability.
| Total Current Assets | 1.75B | 2.17B | 1.03B | 1.13B | 1.29B | 1.28B | 561.05M | 27.41M | 17.48M |
| Cash & Short-Term Investments | 1.45B | 1.83B | 850.87M | 997.84M | 1.18B | 1.18B | 519.65M | 2.76M | 2.83M |
| Cash Only | 429.07M | 1.17B | 282.44M | 263.35M | 136.63M | 1.18B | 519.65M | 2.76M | 2.83M |
| Short-Term Investments | 1.02B | 664.27M | 568.43M | 734.49M | 1.05B | 0 | 0 | 0 | 0 |
| Accounts Receivable | 96.72M | 146.68M | 62.34M | 30.16M | 32.86M | 51.01M | 3.59M | 370K | 225K |
| Days Sales Outstanding | 219.03 | 194.37 | 111.63 | 43.44 | 22.73 | 56.09 | 9.75 | 1.84 | 1.22 |
| Inventory | 173.43M | 171.56M | 107.91M | 95.18M | 57.55M | 38.69M | 32.27M | 23.05M | 13.47M |
| Days Inventory Outstanding | 225.38 | 222.01 | 145.53 | 234.07 | 189.98 | 140.33 | 166.54 | 124.02 | 85.85 |
| Other Current Assets | 0 | 18.27M | 10.2M | 7.99M | 21.07M | 1.34M | 0 | 0 | 947K |
| Total Non-Current Assets | 1.98B | 1.84B | 1.3B | 1.21B | 943.96M | 612.86M | 513.24M | 74.39M | 78.79M |
| Property, Plant & Equipment | 1.61B | 1.38B | 1.26B | 1.17B | 935.84M | 610.61M | 503M | 46.97M | 52.93M |
| Fixed Asset Turnover | 0.11x | 0.20x | 0.16x | 0.22x | 0.56x | 0.54x | 0.27x | 1.56x | 1.27x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 6.17M | 7.37M | 8.88M | 89K | 0 | 0 | 0 | 0 |
| Long-Term Investments | 538K | 538K | 0 | 9.67M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 372.71M | 308.62M | 34.69M | 18.6M | 8.03M | 2.25M | 10.24M | 27.41M | 25.86M |
| Total Assets | 3.73B | 4.01B | 2.33B | 2.34B | 2.24B | 1.89B | 1.07B | 101.79M | 96.27M |
| Asset Turnover | 0.04x | 0.07x | 0.09x | 0.11x | 0.24x | 0.18x | 0.13x | 0.72x | 0.70x |
| Asset Growth % | 258.64% | 71.84% | -0.12% | 4.41% | 18.42% | 75.9% | 955.35% | 5.74% | - |
| Total Current Liabilities | 183.54M | 299.05M | 164.02M | 108.55M | 97.48M | 59.54M | 43.06M | 31.32M | 23.05M |
| Accounts Payable | 46.02M | 36.66M | 23.56M | 28M | 15.33M | 35.73M | 16.16M | 0 | 7.79M |
| Days Payables Outstanding | 48.27 | 47.43 | 31.78 | 68.84 | 50.59 | 129.61 | 83.39 | - | 49.64 |
| Short-Term Debt | 0 | 74.53M | 0 | 0 | 0 | 16.08M | 24.47M | 4.48M | 5.4M |
| Deferred Revenue (Current) | 181.91M | 74.3M | 56.88M | 0 | 0 | 0 | 0 | 6.61M | 0 |
| Other Current Liabilities | 31.64M | 89.56M | 18.85M | 6.62M | 4.05M | 4.01M | 2.16M | 20.03M | 9.86M |
| Current Ratio | 9.51x | 7.24x | 6.29x | 10.42x | 13.27x | 21.44x | 13.03x | 0.88x | 0.76x |
| Quick Ratio | 8.56x | 6.67x | 5.63x | 9.54x | 12.68x | 20.79x | 12.28x | 0.14x | 0.17x |
| Cash Conversion Cycle | 396.14 | 368.94 | 225.38 | 208.66 | 162.13 | 66.82 | 92.91 | - | 37.44 |
| Total Non-Current Liabilities | 1.17B | 1.32B | 1.11B | 862.12M | 827.67M | 821.39M | 177.35M | 88.5M | 84.49M |
| Long-Term Debt | 934.58M | 960.13M | 908.73M | 681.98M | 678.44M | 674.93M | 45.34M | 13.59M | 15.53M |
| Capital Lease Obligations | 31.19M | 8.43M | 5.8M | 6.83M | 15K | 554K | 736K | 399K | 0 |
| Deferred Tax Liabilities | 259.55M | 197.3M | 110.81M | 130.79M | 122.35M | 104.5M | 87.47M | 0 | 0 |
| Other Non-Current Liabilities | 129.79M | 46.64M | 26.11M | 25.09M | 26.86M | 41.41M | 43.8M | 45.57M | 68.96M |
| Total Liabilities | 1.77B | 1.62B | 1.28B | 970.67M | 925.15M | 880.93M | 220.41M | 119.82M | 107.54M |
| Total Debt | 934.58M | 1.04B | 914.53M | 688.81M | 678.46M | 691.82M | 70.82M | 18.67M | 20.93M |
| Net Debt | 505.51M | -122.93M | 632.09M | 425.46M | 541.83M | -487.48M | -448.84M | 15.91M | 18.09M |
| Debt / Equity | 0.48x | 0.44x | 0.87x | 0.50x | 0.52x | 0.69x | 0.08x | - | - |
| Debt / EBITDA | -47.25x | - | - | 18.13x | 1.96x | 3.65x | - | - | - |
| Net Debt / EBITDA | -25.56x | - | - | 11.20x | 1.57x | -2.57x | - | - | - |
| Interest Coverage | -2.90x | -2.74x | -3.06x | 7.30x | 59.96x | 18.99x | -6.88x | -0.98x | -1.77x |
| Total Equity | 1.96B | 2.39B | 1.05B | 1.37B | 1.31B | 1.01B | 853.88M | -18.02M | -11.27M |
| Equity Growth % | 473.68% | 126.79% | -22.76% | 4.05% | 30.13% | 18.14% | 4837.97% | -59.95% | - |
| Book Value per Share | 10.98 | 14.06 | 6.21 | 7.67 | 6.79 | 5.31 | 10.71 | -0.26 | -0.16 |
| Total Shareholders' Equity | 1.96B | 2.39B | 1.05B | 1.37B | 1.31B | 1.01B | 853.88M | -18.02M | -11.27M |
| Common Stock | 19K | 19K | 18K | 17K | 18K | 18K | 17K | 7K | 20.5M |
| Retained Earnings | 206.16M | 234.43M | 320.3M | 385.73M | 361.42M | 72.42M | -62.62M | -40.8M | -34.04M |
| Treasury Stock | -227.05M | -227.05M | -227.05M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -258K | 387K | 173K | 145K | 189K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NdPr price volatility and technical execution
Total assets surged from $2.4B to $3.7B over the past year, per reported balance sheets, while equity doubled to $2.0B, indicating aggressive investment despite persistent operating losses.
The balance sheet has expanded significantly, driven by a $1.6B increase in net PPE as the company invests heavily in Stage II and III facilities. This growth appears funded by a combination of debt and equity issuance, as total liabilities rose from $1.2B to $1.8B. The trajectory suggests a deliberate build-out phase, but the negative retained earnings trend—from $402.2M to $206.2M—indicates that operational losses are eroding equity, warranting close monitoring of the pace of investment versus profitability.
Debt-to-equity improved from 0.83 to 0.48 over the past year, per reported figures, yet total debt increased to $934.6M, suggesting leverage is manageable but absolute obligations are growing.
The D/E ratio has halved due to equity growth, but total debt remains elevated at $934.6M, with a slight increase from $943.7M a year ago. This suggests the company is not aggressively deleveraging but rather growing its equity base faster than debt. The debt appears strategic, funding capital-intensive expansions, but the negative operating margins imply that servicing this debt relies on future cash flows, which are not yet materializing. Investors should monitor the interest coverage ratio as the company continues to burn cash.
Net PPE grew 33% year-over-year to $1.6B, per the latest balance sheet, while goodwill is negligible, indicating a tangible-asset-heavy model with minimal acquisition-related intangibles.
The asset mix is increasingly dominated by property, plant, and equipment, reflecting the build-out of separation and magnet facilities. Goodwill is essentially zero, which is positive as it reduces impairment risk. However, the rapid PPE growth suggests a high fixed-cost structure that may not generate adequate returns if NdPr prices remain weak. The company's ability to amortize these assets over sufficient production volumes will be critical to achieving profitability.
Equity doubled to $2.0B in 2026Q2, per reported data, but retained earnings fell from $402.2M to $206.2M over the past year, indicating that losses are being offset by external capital raises.
The equity increase appears driven by capital raises rather than organic profit retention, as retained earnings have declined by nearly $200M. This suggests dilution for existing shareholders, though the company has also repurchased shares in the past. The negative retained earnings trend indicates that the company is not yet self-sustaining, and the reliance on external funding may pressure future returns if the expansion does not yield expected margins.
Current ratio improved to 9.51 in 2026Q2, per the latest balance sheet, but cash dropped to $429.1M from $1.2B in 2025Q4, indicating a rapid drawdown to fund operations and capex.
Despite a high current ratio, the cash position has declined sharply, from $1.2B to $429.1M in just two quarters, reflecting heavy capital expenditures and negative operating cash flow. The company appears to have a sufficient liquidity buffer for near-term needs, but the burn rate suggests that without additional funding or a turnaround in profitability, cash could be depleted within a few quarters. This warrants close monitoring of the company's ability to access capital markets.
The balance sheet shows $1.6B in net PPE, but capitalized commissioning costs and stripping costs may understate operating expenses, per reported accounting practices, potentially inflating current asset values.
The aggressive capitalization of costs related to the Stage II and III build-out could be masking the true operational cash burn. If these costs were expensed, the negative margins and cash flow would be even more pronounced. Additionally, the sharp decline in cash from $1.2B to $429.1M suggests that the company is consuming cash faster than the balance sheet indicates, as some of the spending is being capitalized. Investors should scrutinize the cash flow statement to understand the sustainability of the current expansion.
Quick answers to the most common questions about buying MP stock.
As of 2025, MP Materials Corp. (MP) had total assets of $4.01B including $2.17B in current assets.
MP Materials Corp. (MP) carries total debt of $1.04B, offset by $1.83B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
MP Materials Corp. (MP) has total shareholders' equity (book value) of $2.39B ($14.06 book value per share). Book value represents the net worth of the company belonging to common stock holders.
MP Materials Corp. (MP) reported a current ratio of 7.24x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.